Publications

Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.

Sirima, SB; Tiono, AB; Ouédraogo, A; Diarra, A; Ouédraogo, AL; Yaro, JB; Ouédraogo, E; Gansané, A; Bougouma, EC; Konaté, AT; Kaboré, Y; Traoré, A; Chilengi, R; Soulama, I; Luty, AJ F; Druilhe, P; COUSENS, S; Nébié, I;

2009

PloS one, (2009).4 10 10.1371/journal.pone.0007549.

Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months.

Lusingu, JP A; Gesase, S; Msham, S; Francis, F; Lemnge, M; Seth, M; Sembuche, S; Rutta, A; Minja, D; Segeja, MD; Bosomprah, S; COUSENS, S; Noor, R; Chilengi, R; Druilhe, P;

2009

Malaria journal, (2009).8 1 10.1186/1475-2875-8-163.

An assessment of methods for routine local monitoring of vaccine efficacy, with particular reference to measles and pertussis.

Clarkson, JA; FINE, PE;

2009

Epidemiology and infection, (2009).99 2 10.1017/s0950268800067996.

Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.

Stewart, M; Bhatia, Y; Athmaran, TN; Noad, R; Gastaldi, C; Dubois, E; Russo, P; Thiéry, R; Sailleau, C; Bréard, E; Zientara, S; ROY, P;

2009

Vaccine, (2009).28 17 10.1016/j.vaccine.2009.10.072.

Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants.

Hesseling, AC; Johnson, LF; Jaspan, H; Cotton, MF; Whitelaw, A; Schaaf, HS; FINE, PE M; Eley, BS; Marais, BJ; Nuttall, J; Beyers, N; GODFREY-FAUSSETT, P;

2009

Bulletin of the World Health Organization, (2009).87 7 10.2471/blt.08.055657.

Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.

Delany-Moretlwe, S; Jentsch, U; WEISS, H; Moyes, J; Ashley-Morrow, R; Stevens, W; MAYAUD, P;

2009

Sexually transmitted infections, (2009).86 1 10.1136/sti.2009.036541.

Epidemiological studies of the non-specific effects of vaccines: II--methodological issues in the design and analysis of cohort studies.

Farrington, CP; Firth, MJ; Moulton, LH; Ravn, H; Andersen, PK; EVANS, S; Working Group on Non-specific Effects of Vaccines,;

2009

Tropical medicine & international health, (2009).14 9 10.1111/j.1365-3156.2009.02302.x.

Toward a Malaria Vaccine The Elusive Malaria Vaccine Miracle or Mirage? by Irwin W. Sherman ASM Press, Washington, DC, 2009. 401 pp. $39.95. ISBN 9781555815158.

GREENWOOD, B;

2009

Science, (2009).326 5951 10.1126/science.1180581.

Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigens.

Duah, NO; WEISS, HA; Jepson, A; TETTEH, KK A; Whittle, HC; CONWAY, DJ;

2009

PloS one, (2009).4 10 10.1371/journal.pone.0007381.

Epidemiological studies of the 'non-specific effects' of vaccines: I--data collection in observational studies.

FINE, PE M; Williams, TN; Aaby, P; Källander, K; Moulton, LH; Flanagan, KL; SMITH, PG; Benn, CS; Working Group on Non-specific Effects of Vaccines,;

2009

Tropical medicine & international health, (2009).14 9 10.1111/j.1365-3156.2009.02301.x.